Ditchcarbon
  • Customers
  1. Organizations
  2. BioDelivery Sciences International, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

BioDelivery Sciences International, Inc.

Company website

BioDelivery Sciences International, Inc. (BDSI), headquartered in the United States, is a pioneering biopharmaceutical company focused on developing and commercialising innovative therapeutics for patients with chronic pain and substance use disorders. Founded in 1997, BDSI has achieved significant milestones, including the successful launch of its flagship product, BELBUCA®, a buprenorphine film that offers a unique delivery system for pain management. Operating primarily in the biopharmaceutical industry, BDSI is dedicated to advancing its proprietary drug delivery technologies, which enhance the efficacy and safety of its products. With a strong market position, BDSI has garnered recognition for its commitment to improving patient outcomes and addressing unmet medical needs. The company continues to expand its portfolio, solidifying its role as a leader in the field of pain management and addiction treatment.

DitchCarbon Score

How does BioDelivery Sciences International, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

BioDelivery Sciences International, Inc.'s score of 25 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

30%

Let us know if this data was useful to you

BioDelivery Sciences International, Inc.'s reported carbon emissions

BioDelivery Sciences International, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Collegium Pharmaceutical, Inc., which may influence its climate commitments and reporting practices. As of now, BioDelivery Sciences has not established any documented reduction targets or initiatives related to carbon emissions. There are no commitments to the Science Based Targets initiative (SBTi) or other climate pledges that would typically guide corporate sustainability efforts. Given the lack of specific emissions data and reduction initiatives, it is unclear how BioDelivery Sciences International, Inc. is addressing climate change within its operational framework. The company may benefit from aligning with industry standards and setting measurable targets to enhance its environmental impact and transparency.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. BioDelivery Sciences International, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for BioDelivery Sciences International, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

BioDelivery Sciences International, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Ironwood Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

LTS Lohmann Therapie-Systeme AG

DE
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Mallinckrodt plc

IE
•
Pharmaceutical Preparation Manufacturing
Updated about 16 hours ago

DMK Pharmaceuticals Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Apn Outdoor Group Limited

AU
•
Other business services (74)
Updated 10 days ago

Aquestive Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250804.4
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy